Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Oncotarget|January 2, 2018
Defined, serum/feeder-free conditions for expansion and drug screening of primary B-acute lymphoblastic leukemiaZhiwu Jiang, Di Wu, Wei Ye, et al.EMBO Reports|April 19, 2022
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factorsZhiwu Jiang, Lin Cheng, Zhiping Wu, et al.Molecular Therapy Oncolytics|July 5, 2022
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Ruocong Zhao, Diwei Zheng, et al.Nature Communications|October 13, 2022
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axisLe Qin, Yuanbin Cui, Tingjie Yuan, et al.Frontiers in Immunology|December 20, 2017
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor ProgressionShouheng Lin, Guohua Huang, Yiren Xiao, et al.Mabs|September 12, 2018
Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapyShouheng Lin, Guohua Huang, Lin Cheng, et al.Journal of Hematology & Oncology|February 20, 2019
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancerJiang Lv, Ruocong Zhao, Di Wu, et al.Leukemia|November 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cellsZhiwu Jiang, Rui Liao, Jiang Lv, et al.Biomarker Research|March 25, 2022
Human induced-T-to-natural killer cells have potent anti-tumour activitiesZhiwu Jiang, Le Qin, Yuou Tang, et al.Pageof 4